|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5585362A
(en)
|
1989-08-22 |
1996-12-17 |
The Regents Of The University Of Michigan |
Adenovirus vectors for gene therapy
|
|
CA2115742A1
(en)
|
1991-08-20 |
1993-03-04 |
Ronald G. Crystal |
Adenovirus mediated transfer of genes to the gastrointestinal tract
|
|
US5252479A
(en)
|
1991-11-08 |
1993-10-12 |
Research Corporation Technologies, Inc. |
Safe vector for gene therapy
|
|
FR2688514A1
(fr)
|
1992-03-16 |
1993-09-17 |
Centre Nat Rech Scient |
Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
|
|
JPH08503855A
(ja)
|
1992-12-03 |
1996-04-30 |
ジェンザイム・コーポレイション |
嚢胞性線維症に対する遺伝子治療
|
|
AU687829B2
(en)
|
1993-06-24 |
1998-03-05 |
Advec, Inc. |
Adenovirus vectors for gene therapy
|
|
JP3875990B2
(ja)
|
1993-10-25 |
2007-01-31 |
カンジ，インコーポレイテッド |
組換えアデノウイルスベクターおよび使用方法
|
|
US5635363A
(en)
|
1995-02-28 |
1997-06-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for the detection, quantitation and purification of antigen-specific T cells
|
|
US5869270A
(en)
|
1996-01-31 |
1999-02-09 |
Sunol Molecular Corporation |
Single chain MHC complexes and uses thereof
|
|
US6211342B1
(en)
|
1996-07-18 |
2001-04-03 |
Children's Hospital Medical Center |
Multivalent MHC complex peptide fusion protein complex for stimulating specific T cell function
|
|
US20050003431A1
(en)
|
1996-08-16 |
2005-01-06 |
Wucherpfennig Kai W. |
Monovalent, multivalent, and multimeric MHC binding domain fusion proteins and conjugates, and uses therefor
|
|
DE69836209D1
(de)
|
1997-02-13 |
2006-11-30 |
Univ California |
Vorbeugung und behandlunhg des hepatozellulären krebses
|
|
US7098306B2
(en)
|
1997-02-13 |
2006-08-29 |
The Regents Of The University Of California |
Method and compositions for treating hepatocellular cancer
|
|
US6268411B1
(en)
|
1997-09-11 |
2001-07-31 |
The Johns Hopkins University |
Use of multivalent chimeric peptide-loaded, MHC/ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses
|
|
US20030007978A1
(en)
|
1997-09-16 |
2003-01-09 |
Burrows Gregory G. |
Recombinant MHC molecules useful for manipulation of antigen-specific T-cells
|
|
US7078387B1
(en)
|
1998-12-28 |
2006-07-18 |
Arch Development Corp. |
Efficient and stable in vivo gene transfer to cardiomyocytes using recombinant adeno-associated virus vectors
|
|
US6696304B1
(en)
|
1999-02-24 |
2004-02-24 |
Luminex Corporation |
Particulate solid phase immobilized protein quantitation
|
|
US7446189B1
(en)
*
|
1999-04-30 |
2008-11-04 |
Institut De Recherches Cliniques De Montreal |
Nucleic acids encoding mutant human CD80 and compositions comprising the same
|
|
US20020006664A1
(en)
|
1999-09-17 |
2002-01-17 |
Sabatini David M. |
Arrayed transfection method and uses related thereto
|
|
US6287860B1
(en)
|
2000-01-20 |
2001-09-11 |
Isis Pharmaceuticals, Inc. |
Antisense inhibition of MEKK2 expression
|
|
CA2410642A1
(en)
|
2000-05-25 |
2001-11-29 |
Sunol Molecular Corporation |
Modulation of t-cell receptor interactions
|
|
US20020122820A1
(en)
|
2001-01-16 |
2002-09-05 |
Hildebrand William H. |
Soluble MHC artificial antigen presenting cells
|
|
US6800748B2
(en)
|
2001-01-25 |
2004-10-05 |
Large Scale Biology Corporation |
Cytoplasmic inhibition of gene expression and expression of a foreign protein in a monocot plant by a plant viral vector
|
|
WO2002072631A2
(en)
|
2001-03-14 |
2002-09-19 |
Dakocytomation Denmark A/S |
Mhc molecule constructs and their usesfor diagnosis and therapy
|
|
WO2002093129A2
(en)
|
2001-05-15 |
2002-11-21 |
University Of Medicine & Dentistry Of New Jersey |
Methods for analyzing interactions between proteins in live and intact cells
|
|
WO2002099089A1
(en)
|
2001-06-04 |
2002-12-12 |
Corixa Corporation |
Compositions and methods for high-level, large-scale production of recombinant proteins
|
|
US20030017134A1
(en)
|
2001-06-19 |
2003-01-23 |
Technion Research And Development Foundation Ltd. |
Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer
|
|
EP1497426A2
(en)
|
2001-06-22 |
2005-01-19 |
Maxygen, Inc. |
Co-stimulatory molecules
|
|
WO2003006632A2
(en)
|
2001-07-12 |
2003-01-23 |
Canvac |
Methods and compisitions for activation human t cells in vitro
|
|
US20040038349A1
(en)
|
2001-07-27 |
2004-02-26 |
Hilbert David M. |
Heteromultimeric TNF ligand family members
|
|
EP2354791A1
(en)
|
2001-12-04 |
2011-08-10 |
Merck Patent GmbH |
Immunocytokines with modulated selectivity
|
|
US8895020B2
(en)
|
2002-04-19 |
2014-11-25 |
Washington University |
Single chain trimers and uses therefor
|
|
ATE466085T1
(de)
|
2002-09-09 |
2010-05-15 |
Hanall Pharmaceutical Co Ltd |
Protease-resistente modifizierte interferon alpha polypeptide
|
|
US7432351B1
(en)
|
2002-10-04 |
2008-10-07 |
Mayo Foundation For Medical Education And Research |
B7-H1 variants
|
|
CA2516832A1
(en)
|
2003-02-27 |
2004-09-10 |
Theravision Gmbh |
A molecule which binds cd80 and cd86
|
|
AU2003901876A0
(en)
|
2003-04-17 |
2003-05-08 |
The Macfarlane Burnet Institute For Medical Research And Public Health |
Viral vector
|
|
US20050042641A1
(en)
|
2003-05-27 |
2005-02-24 |
Cold Spring Harbor Laboratory |
In vivo high throughput selection of RNAi probes
|
|
EP2783699A1
(en)
|
2003-09-05 |
2014-10-01 |
Oregon Health & Science University |
Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T cells
|
|
US7470513B2
(en)
|
2003-11-10 |
2008-12-30 |
Academia Sinica |
Risk assessment for adverse drug reactions
|
|
CA2557677A1
(en)
|
2004-03-05 |
2005-10-06 |
Chiron Corporation |
In vitro test system for predicting patient tolerability of therapeutic agents
|
|
DE102004014983A1
(de)
|
2004-03-26 |
2005-10-20 |
Univ Stuttgart |
Rekombinante Polypeptide der Mitglieder der TNF Ligandenfamilie und deren Verwendung
|
|
CA2567814C
(en)
|
2004-05-27 |
2013-07-23 |
Jon A. Weidanz |
Antibodies as t cell receptor mimics, methods of production and uses thereof
|
|
US7670595B2
(en)
|
2004-06-28 |
2010-03-02 |
Merck Patent Gmbh |
Fc-interferon-beta fusion proteins
|
|
EP1996220B2
(en)
|
2006-03-06 |
2023-08-16 |
Amunix Operating Inc. |
Unstructured recombinant polymers and uses thereof
|
|
US7855279B2
(en)
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
|
CA2523032A1
(en)
|
2005-10-07 |
2007-04-07 |
Immunovaccine Technologies Inc. |
Vaccines for cancer therapy
|
|
BRPI0618449A2
(pt)
|
2005-11-10 |
2011-08-30 |
Receptor Biologix Inc |
métodos para produção de isoformas de receptor e ligante
|
|
US8518697B2
(en)
|
2006-04-04 |
2013-08-27 |
Washington University |
Single chain trimers and uses therefor
|
|
AU2007254167B2
(en)
|
2006-05-19 |
2012-11-15 |
Technion Research And Development Foundation Ltd. |
Fusion proteins, uses thereof and processes for producing same
|
|
EP1889851A1
(en)
|
2006-08-18 |
2008-02-20 |
Charite Universitätsmedizin-Berlin |
PAX2 and PAX8 as targets for immunologic and molecular tumour treatment strategies
|
|
US8992937B2
(en)
|
2006-08-28 |
2015-03-31 |
Washington University |
Disulfide trap MHC class I molecules and uses therefor
|
|
EP2980219B1
(en)
|
2006-12-28 |
2018-11-14 |
International Institute of Cancer Immunology, Inc. |
Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same
|
|
ES2527412T3
(es)
|
2007-02-15 |
2015-01-23 |
Mannkind Corporation |
Método para aumentar la respuesta de los linfocitos T
|
|
WO2008113970A2
(en)
|
2007-03-16 |
2008-09-25 |
Ucl Business Plc |
Peptides
|
|
EP2361930A3
(en)
|
2007-03-26 |
2011-10-26 |
Dako Denmark A/S |
Multimers of MHC-peptide complexes and uses thereof in Borrelia infectious diseases
|
|
CA2685326A1
(en)
|
2007-04-27 |
2008-11-06 |
Dow Global Technologies Inc. |
Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
|
|
BRPI0815416A2
(pt)
|
2007-08-15 |
2014-10-21 |
Amunix Inc |
Composições e métodos para modificar propriedades de polipeptídeos biologicamente ativos
|
|
US8926961B2
(en)
|
2007-10-03 |
2015-01-06 |
Board Of Trustees Of The University Of Arkansas |
HPV E6 protein T cell epitopes and uses thereof
|
|
CN101418309B
(zh)
|
2007-10-23 |
2011-05-04 |
中国农业科学院上海兽医研究所 |
柔嫩艾美耳球虫蛋白质二硫键异构酶基因的克隆、表达及应用
|
|
DE102008023820A1
(de)
|
2008-05-08 |
2009-11-12 |
Aicuris Gmbh & Co. Kg |
Mittel zur Behandlung und/oder Prophylaxe einer Autoimmunerkrankung und zur Bildung von Regulatorischen T-Zellen
|
|
TW201008574A
(en)
|
2008-08-19 |
2010-03-01 |
Oncotherapy Science Inc |
INHBB epitope peptides and vaccines containing the same
|
|
EP2337795A2
(en)
|
2008-10-01 |
2011-06-29 |
Dako Denmark A/S |
Mhc multimers in cancer vaccines and immune monitoring
|
|
EP2184070A1
(en)
|
2008-11-07 |
2010-05-12 |
Hla-G Technologies |
HLA-G proteins and pharmaceutical uses thereof
|
|
US20110274650A1
(en)
|
2009-01-21 |
2011-11-10 |
Amgen Inc. |
Compositions and methods of treating inflammatory and autoimmune diseases
|
|
EA020843B1
(ru)
|
2009-02-03 |
2015-02-27 |
Амуникс Оперейтинг Инк. |
Удлиненные рекомбинантные полипептиды и содержащие их композиции
|
|
US9359424B2
(en)
|
2009-06-25 |
2016-06-07 |
Commissariat A L'energie Atomique Et Aux Energies Alternatives |
Multimeric polypeptides of HLA-G including alpha1-alpha3 monomers and pharmaceutical uses thereof
|
|
JP2013512251A
(ja)
|
2009-11-24 |
2013-04-11 |
アンプリミューン、インコーポレーテッド |
Ｐｄ−ｌ１／ｐｄ−ｌ２の同時阻害
|
|
LT3279215T
(lt)
|
2009-11-24 |
2020-04-10 |
Medimmune Limited |
Tiksliniai surišantys agentai prieš b7-h1
|
|
EP4385570A3
(en)
|
2010-09-21 |
2024-09-11 |
Altor BioScience, LLC |
Multimeric il-15 soluble fusion molecules and methods of making and using same
|
|
CA2860170C
(en)
|
2010-12-22 |
2022-06-14 |
The Board Of Trustees Of The Leland Stanford Junior University |
Superagonists and antagonists of interleukin-2
|
|
WO2012127464A2
(en)
|
2011-03-23 |
2012-09-27 |
Gavish-Galilee Bio Applications Ltd |
Constitutively activated t cells for use in adoptive cell therapy
|
|
AU2012274127B2
(en)
|
2011-06-22 |
2017-06-22 |
F. Hoffmann-La Roche Ag |
Removal of target cells by circulating virus-specific cytotoxic T-cells using MHC class I comprising complexes
|
|
EP3357511B1
(en)
|
2011-06-30 |
2020-05-13 |
Genzyme Corporation |
Inhibitors of t-cell activation
|
|
DE112011100879A5
(de)
|
2011-08-30 |
2013-11-14 |
Jacobs University Bremen Ggmbh |
Gen codiert für ein MHC-Klasse-I-Molekül, Plasmid, Expressionssystem, Protein, Multimer, Reagenz und Kit zum Analysieren einer T-Zellen-Frequenz
|
|
US8956619B2
(en)
|
2011-10-25 |
2015-02-17 |
University Of Maryland, Baltimore County |
Soluble CD80 as a therapeutic to reverse immune supression in cancer patients
|
|
LT2785375T
(lt)
|
2011-11-28 |
2020-11-10 |
Merck Patent Gmbh |
Anti-pd-l1 antikūnai ir jų panaudojimas
|
|
EP2802347B1
(en)
|
2012-01-13 |
2019-01-09 |
Memorial Sloan Kettering Cancer Center |
Immunogenic wt-1 peptides and methods of use thereof
|
|
EP2809345A4
(en)
|
2012-02-03 |
2015-11-25 |
Univ Emory |
IMMUNOSTIMULATING COMPOSITIONS, PARTICLES THEREFOR, AND USES THEREFOR
|
|
US20140044675A1
(en)
|
2012-08-10 |
2014-02-13 |
Roche Glycart Ag |
Interleukin-2 fusion proteins and uses thereof
|
|
EP2925780B1
(en)
|
2012-11-30 |
2017-10-18 |
Roche Glycart AG |
Removal of cancer cells by circulating virus-specific cytotoxic t-cells using cancer cell targeted mhc class i comprising multi-function proteins
|
|
BR112015013557B1
(pt)
|
2012-12-11 |
2021-12-14 |
Albert Einstein College Of Medicine |
Sistema, método, método para determinar o efeito de um resíduo de aminoácido predeterminado de uma primeira proteína sobre a ligação da primeira proteína a uma segunda proteína e polipeptídeo pd-l1 mutante
|
|
WO2014096015A1
(en)
|
2012-12-21 |
2014-06-26 |
F. Hoffmann-La Roche Ag |
Disulfide-linked multivalent mhc class i comprising multi-function proteins
|
|
US10815273B2
(en)
|
2013-01-15 |
2020-10-27 |
Memorial Sloan Kettering Cancer Center |
Immunogenic WT-1 peptides and methods of use thereof
|
|
WO2014116846A2
(en)
|
2013-01-23 |
2014-07-31 |
Abbvie, Inc. |
Methods and compositions for modulating an immune response
|
|
WO2014157692A1
(ja)
|
2013-03-29 |
2014-10-02 |
大日本住友製薬株式会社 |
Ｗｔ１抗原ペプチドコンジュゲートワクチン
|
|
GB201311475D0
(en)
|
2013-06-27 |
2013-08-14 |
Alligator Bioscience Ab |
Polypeptides
|
|
AU2014291961B2
(en)
|
2013-07-19 |
2018-09-27 |
Centre Hospitalier Regional Universitaire De Montpellier |
Targeted modified TNF family members
|
|
JP6875126B2
(ja)
|
2014-01-21 |
2021-05-19 |
アルバート アインシュタイン カレッジ オブ メディシン |
迅速かつ包括的なｔ細胞免疫モニタリング用の細胞プラットフォーム
|
|
US20160152725A1
(en)
|
2014-02-25 |
2016-06-02 |
Memorial Sloan-Kettering Cancer Center |
Antigen-binding proteins specific for hla-a2-restricted wilms tumor 1 peptide
|
|
WO2015129790A1
(ja)
|
2014-02-26 |
2015-09-03 |
株式会社バイオイミュランス |
Ｗｔ１抗原性ポリペプチド、及び該ポリペプチドを含む抗腫瘍剤
|
|
US10150802B2
(en)
|
2014-04-24 |
2018-12-11 |
The Board Of Trustees Of The Leland Stanford Junior University |
Superagonists, partial agonists and antagonists of interleukin-2
|
|
US20170058015A1
(en)
*
|
2014-06-18 |
2017-03-02 |
Albert Einstein College Of Medicine, Inc. |
Syntac polypeptides and uses thereof
|
|
JP6526189B2
(ja)
|
2014-07-03 |
2019-06-05 |
ベイジーン リミテッド |
抗ｐｄ−ｌ１抗体並びにその治療及び診断のための使用
|
|
KR102493543B1
(ko)
|
2014-07-21 |
2023-01-30 |
데리니아, 인크. |
자가면역 질환의 치료를 위한 조절 t 세포를 선택적으로 활성화시키는 분자
|
|
EP3180018B1
(en)
|
2014-08-12 |
2019-07-24 |
Massachusetts Institute Of Technology |
Synergistic tumor treatment with il-2 and integrin-binding-fc-fusion protein
|
|
US11111284B2
(en)
|
2014-08-21 |
2021-09-07 |
The General Hospital Corporation |
Tumor necrosis factor superfamily and TNF-like ligand muteins and methods of preparing
|
|
RS59939B1
(sr)
|
2014-08-29 |
2020-03-31 |
Hoffmann La Roche |
Kombinovana terapija il-2 varijantom imunocitokina sa ciljanim delovanjem na tumor i antitelima na humani pd-l1
|
|
MY196588A
(en)
|
2015-03-05 |
2023-04-19 |
Hutchinson Fred Cancer Res |
Immunomodulatory Fusion Proteins and uses Thereof
|
|
PT3283508T
(pt)
|
2015-04-17 |
2021-06-21 |
Alpine Immune Sciences Inc |
Proteínas imuno modulatórias com afinidades afináveis
|
|
WO2017008844A1
(en)
|
2015-07-14 |
2017-01-19 |
Biontech Ag |
Peptide mimotopes of the cd3 t-cell co-receptor epsilon chain and uses thereof
|
|
EP3328377A4
(en)
|
2015-07-31 |
2019-03-13 |
Tarveda Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR IMMUNE ONCOLOGY THERAPIES
|
|
CN106565836B
(zh)
|
2015-10-10 |
2020-08-18 |
中国科学院广州生物医药与健康研究院 |
高亲和力的可溶性pdl-1分子
|
|
CA3005896C
(en)
|
2015-11-20 |
2025-09-23 |
Memorial Sloan Kettering Cancer Center |
METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER BY MEANS OF THE COMBINATION OF A WT1 PEPTIDE AND A CHECKPOINT INHIBITOR
|
|
CA3009799A1
(en)
|
2016-01-04 |
2017-07-13 |
Cour Pharmaceuticals Development Company Inc. |
Particles encapsulating fusion proteins containing linked epitopes
|
|
WO2017151818A2
(en)
|
2016-03-02 |
2017-09-08 |
Cue Biopharma, Inc. |
T-cell modulatory multimeric polypeptides and methods of use thereof
|
|
US20190046648A1
(en)
*
|
2016-03-03 |
2019-02-14 |
Cue Biopharma, Inc. |
T-cell modulatory multimeric polypeptides and methods of use thereof
|
|
KR20250133490A
(ko)
|
2016-05-04 |
2025-09-05 |
암젠 인크 |
T-조절 세포의 증식을 위한 인터류킨-2 뮤테인
|
|
CN109689096A
(zh)
|
2016-05-18 |
2019-04-26 |
阿尔伯特爱因斯坦医学院公司 |
变体pd-l1多肽、t细胞调节性多聚体多肽及其使用方法
|
|
KR20190019068A
(ko)
|
2016-05-18 |
2019-02-26 |
큐 바이오파마, 인크. |
T-세포 조절 다량체 폴리펩타이드 및 이의 사용 방법
|
|
PT3558339T
(pt)
|
2016-12-22 |
2024-03-15 |
Cue Biopharma Inc |
Polipeptídeos multiméricos moduladores de células t e métodos de utilização dos mesmos
|
|
US11851471B2
(en)
*
|
2017-01-09 |
2023-12-26 |
Cue Biopharma, Inc. |
T-cell modulatory multimeric polypeptides and methods of use thereof
|
|
CA3054955A1
(en)
|
2017-03-15 |
2018-09-20 |
Cue Biopharma, Inc. |
Methods for modulating an immune response
|
|
WO2019051126A1
(en)
|
2017-09-07 |
2019-03-14 |
Cue Biopharma, Inc. |
ANTIGEN PRESENTING POLYPEPTIDES COMPRISING CHEMICAL CONJUGATION SITES AND METHODS OF USE THEREOF
|
|
CA3074839A1
(en)
*
|
2017-09-07 |
2019-03-14 |
Cue Biopharma, Inc. |
T-cell modulatory multimeric polypeptide with conjugation sites and methods of use thereof
|
|
AU2018328283A1
(en)
*
|
2017-09-07 |
2020-02-20 |
Cue Biopharma, Inc. |
Antigen-presenting polypeptides and methods of use thereof
|
|
IL272085B2
(en)
*
|
2017-09-07 |
2023-03-01 |
Cue Biopharma Inc |
Multimeric t-cell modulatory polypeptides and methods of use thereof
|
|
EP3737689A4
(en)
*
|
2018-01-09 |
2021-12-01 |
Cue Biopharma, Inc. |
MULTIMER POLYPEPTIDES T-LYMPHOCYTE MODULATORS AND THEIR METHODS OF USE
|
|
WO2020132135A1
(en)
*
|
2018-12-19 |
2020-06-25 |
Cue Biopharma, Inc. |
Multimeric t-cell modulatory polypeptides and methods of use thereof
|
|
TWI856047B
(zh)
*
|
2018-12-19 |
2024-09-21 |
美商信號生物製藥公司 |
多聚體ｔ細胞調節多肽及其使用方法
|
|
WO2020132368A1
(en)
*
|
2018-12-19 |
2020-06-25 |
Cue Biopharma, Inc. |
T-cell modulatory multimeric polypeptides with conjugation sites and methods of use thereof
|
|
WO2020132136A1
(en)
*
|
2018-12-19 |
2020-06-25 |
Cue Biopharma, Inc. |
Multimeric t-cell modulatory polypeptides and methods of use thereof
|
|
MX2021014476A
(es)
*
|
2019-05-29 |
2022-02-11 |
Cue Biopharma Inc |
Polipeptidos multimericos moduladores de linfocitos t y metodos de uso de estos.
|
|
WO2020257191A1
(en)
*
|
2019-06-19 |
2020-12-24 |
Cue Biopharma, Inc. |
Multimeric t-cell modulatory polypeptides and methods of use thereof
|
|
WO2021081239A1
(en)
*
|
2019-10-23 |
2021-04-29 |
Cue Biopharma, Inc. |
T-cell modulatory chimeric molecules and methods of use thereof
|
|
WO2021195108A1
(en)
*
|
2020-03-24 |
2021-09-30 |
Cue Biopharma, Inc. |
T cell modulatory polypeptides and methods of use thereof
|
|
WO2021231376A2
(en)
*
|
2020-05-12 |
2021-11-18 |
Cue Biopharma, Inc. |
Multimeric t-cell modulatory polypeptides and methods of use thereof
|
|
US20230218731A1
(en)
*
|
2020-05-26 |
2023-07-13 |
Cue Biopharma, Inc. |
Antigen Presenting Polypeptide Complexes and Methods of Use Thereof
|
|
US20230201335A1
(en)
*
|
2020-05-26 |
2023-06-29 |
Cue Biopharma, Inc. |
Antigen Presenting Polypeptide Complexes and Methods of Use Thereof
|
|
CN113823723A
(zh)
|
2020-06-18 |
2021-12-21 |
光宝光电(常州)有限公司 |
发光二极管封装结构
|
|
AU2021309842A1
(en)
*
|
2020-07-14 |
2023-02-16 |
Cue Biopharma, Inc. |
T-cell modulatory polypeptides with conjugation sites and methods of use thereof
|
|
US20230414777A1
(en)
*
|
2020-11-06 |
2023-12-28 |
Cue Biopharma, Inc. |
Antigen Presenting Polypeptide Complexes and Methods of Use Thereof
|
|
CA3174142A1
(en)
*
|
2020-11-06 |
2022-05-12 |
Ronald D. Seidel Iii |
T-cell modulatory polypeptides with conjugation sites and methods of use thereof
|
|
WO2022226054A2
(en)
*
|
2021-04-21 |
2022-10-27 |
Cue Biopharma, Inc. |
Antigen presenting polypeptide complexes bearing tgf-beta and methods of use thereof
|
|
US20240270815A1
(en)
*
|
2021-05-26 |
2024-08-15 |
Cue Biopharma, Inc. |
Antigen Presenting Polypeptide Complexes and Methods of Use Thereof
|
|
WO2023137158A2
(en)
*
|
2022-01-13 |
2023-07-20 |
Cue Biopharma, Inc. |
T cell modulatory polypeptides with conjugation sites and methods of use thereof
|
|
WO2023137156A2
(en)
*
|
2022-01-13 |
2023-07-20 |
Cue Biopharma, Inc. |
T cell modulatory polypeptides with conjugation sites and methods of use thereof
|